Doctors Predict Benefits of Ultrasound Enhancing Agents
Retrieved on:
Friday, October 1, 2021
General Health, Medical Devices, Hospitals, Health, Radiology, Microcirculation, Harvard Medical School, Assistant, Degenerative disease, Queen's University, Heart rate, Diagnosis, Chemistry (relationship), Plaque, Patient, Common carotid artery, Beth Israel Deaconess Medical Center, ICUS, Health, Physician, Mid America Heart Institute, Heart, Echocardiography, Atheroma, UEA, Risk, Liver, Obesity, Laboratory, CEUS, Union of UEA Students, Medical imaging
Doctors today described new ways to predict whether specific patients will benefit from the use of ultrasound enhancing agents (UEAs) to improve the accuracy of their ultrasound scan for diagnosis of heart disease, the number one killer of Americans.
Key Points:
- Doctors today described new ways to predict whether specific patients will benefit from the use of ultrasound enhancing agents (UEAs) to improve the accuracy of their ultrasound scan for diagnosis of heart disease, the number one killer of Americans.
- Dr. Strom also is a member of the board of directors of the International Contrast Ultrasound Society (ICUS).
- Doctors also were encouraged to use UEAs to enhance ultrasound images of carotid arteries.
- UEAs (sometimes also known as ultrasound contrast agents) are injected during an ultrasound scan to enhance the resolution of an ultrasound image of the heart and other organ systems.